<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5286393 Figure_1-A</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Quantitative analysis of Rnf114 mRNA by realtime-PCR in various mouse tissues and organs shows that Rnf114 was predominately expressed in oocytes.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_1-B</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Immunohistochemistry analysis of RNF114 in mouse ovary shows that RNF114 was mainly expressed in the oocytes (Scale bar = 100um).</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_1-C</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Knockdown efficiency of Rnf114 in the 2-cell stage embryos derived from Rnf114 siRNA #1 or siRNA #2 injected zygotes was verified by realtime-PCR and western blotting. NC indicates negative control injected with non-silencing siRNA. Three independent experiment replicates were performed for realtime-PCR, error bars represent s.e.m.; **:P&lt;0.01, ***:P&lt;0.01 in unpaired two-tailed t-test.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_1-D</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) RNF114 depletion impaired the early embryonic development. Rnf114 siRNA #1 or siRNA #2 injected zygotes were cultured and quantified (siRNA1#, n = 120; siRNA2#, n = 128; three independent experiments); NC indicates negative control (n = 193; six independent experiments). The error bars represent s.d., *:P&lt;0.05, **:P&lt;0.01, ***:P&lt;0.001 in unpaired two-tailed t-test.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_1-E</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Representative images to show early embryonic development defects. The embryos arrested at two-cell stage are indicated by arrows (Scale bar = 100um).</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_2-A</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) In vitro ubiquitination assay. Purified His-RNF114 was subjected to ubiquitination assays with the indicated components and the samples were analyzed by immunoblotting with anti-FLAG (Ub) antibody. Lanes 1-4 indicate negative controls. The results show that recombinant RNF114 efficiently catalyzed the formation of polyubiquitin chains.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_2-B-C</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 2-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(B, C) Purified wild-type and RING mutated His-RNF114 were stained by Coomassie Blue (B). Purified wild-type and RING mutated His-RNF114 were subjected to ubiquitination assays together with E1, Ubc4, FLAG-Ub, and ATP. The results show that mutant RNF114 lacked ubiquitination activity (C).</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_2-D</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Screening for proteins ubiquitinated by RNF114 on a proteome array. Putative substrates of RNF114 were identified on Ubiquitin Ligase Substrate Identification on ProtoArray&#174; Human Protein Microarrays v5.0. Ubiquitination reactions were performed on quintuplicate arrays using the indicated components, the five sub-array are respectively negative controls, E1+E2 (no E3), WT RNF114 (two arrays, duplicate), and mutated RNF114.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_2-E</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) A heat map comparing hits between E1+E2, E1+E2+WT RNF114, and E1+E2+mutated RNF114 reactions. Candidate substrates of RNF114 selected for further characterization are indicated in red font; HIP1, indicated by blue font, was considered to be a false positive because it was also detected in the mutated RNF114 reaction. Black font indicates proteins with ubiquitin-binding domains such as UIM, UBA or CUE or proteins without clearly reported functions, which were excluded from further investigation.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_3-A</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) RNF114 substrate validation. HEK293 cells were co-transfected with constructs expressing FLAG-tagged substrates, wild-type or mutated His-RNF114 and EGFP, and western blot was performed with anti-FLAG and anti-His antibodies. The results show that the protein levels of CD74, TAB1, OPTN, TNIP1, APPL1, PSAT1, and RALGPS1 were reduced in the presence of wild-type RNF114 compared to co-transfecting with mutant RNF114.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_3-B</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) RNF114-dependent in vitro ubiquitination of substrates. Substrate ubiquitination assays were performed with purified RNF114, the reaction products were immunoblotted using anti-His antibody to detect the ubiquitin (upper panel) or anti-FLAG antibody detecting the substrate protein (middle panel), and the lower panel showed the merged signals. The results show that clear polyubiquitin chains were formed in the systems containing recombinant CD74, TAB1, TNIP1, PSAT1 or RALGPS1.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_4-A</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) Mouse zygotes were microinjected with sterile ddH2O (control group) or Ralgps1, Cd74, Tnip1, Psat1, or Tab1 mRNA. During 96-100 h culturing, the percentages of embryos at various stages were counted under microscopy. The results show that overexpression of Tab1 impaired the early embryonic development. Three independent experiment replicates were performed, error bars represent s.d.; *:P&lt;0.05, ***:P&lt;0.001 in unpaired two-tailed t-test.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_4-B</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) TAB1 reduced with mouse early embryonic development, while abnormally accumulated at 2-cell stage once treated with Rnf114 siRNAs. TAB1 was detected by western blotting with anti-TAB1 antibody. The relative level of TAB1 protein after Rnf114 siRNAs treatment were presented as mean&#177;s.e.m. (*:P&lt;0.05 in unpaired two-tailed t-test, four independent experiment replicates).</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_4-C</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Detection of endogenous TAB1 ubiquitination at 1-cell or 2-cell stages. Endogenous TAB1 proteins were immunoprecipated by anti-TAB1 antibody at either 1-cell or 2-cell stages, the immunoprecipates were detected by either anti-TAB1 antibody or anti-ubiquitin antibody. The results show that more Ub chains on TAB1 were detected in the two cell stage embryos than in the zygotes, when the TAB1 proteins were at comparable level.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_4-D</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) RNF114-dependent TAB1 degradation during early embryo development. (a-c) Representive time lapse embryo images were shown for each treatment. Scale bar = 20um. (a'-c') Quantification of the GFP fluorescent signals for respective treatments in (a-c). n=14, 9 or 12 for the NC, Rnf114 siRNA1# or Rnf114 siRNA2# treatment group respectively. Gray traces: Tab1-GFP fluorescent signals were normalized to the first time point; Black trace: average signal of all embryos for each treatment.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_4-E</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Tab1 knockdown partly rescued the early embryo development defect observed with Rnf114 knockdown. Both Rnf114 and Tab1 siRNAs were injected into the GV oocytes, then the oocytes matured, and were fertilized by IVF, and the fertilized eggs were transferred into KSOM media, cultured for 48-50 h. The percentages of embryos arrested at 2-cell stage were counted. Three independent experiment replicates were performed, error bars represent s.d.; **:P&lt;0.01 in unpaired two-tailed t-test.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_5-A</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A) NF-&#954;B activation during MZT. Immunofluorescence staining of p65 shows nuclear translocation of p65 at the two-cell stage and thereafter. Scale bar = 25um.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_5-B</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) The protein levels of I&#954;B&#945; and its phosphorylated form (p-I&#954;B&#945;) during mouse early embryonic development were detected by western blotting, representative western blotting of I&#954;B&#945; and p-I&#954;B&#945; was shown on the left and the quantitation analysis (right panel) indicated that the ratio of p-I&#954;B&#945;/total I&#954;B&#945; was gradually increased from MII oocytes to 4-cell stage embryos (three independent experiment replicates were performed, error bars represent s.e.m.).</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_5-C</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) NF-&#954;B pathway inhibition using the specific inhibitor Bay11-7082 resulted in two cell stage arrest. Three independent experiment replicates were performed, error bars represent s.d.; ***:P&lt;0.001 in unpaired two-tailed t-test.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_5-D-E</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 5-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>(D, E) Representive immunofluorescence staining of p65 after knockdown of Rnf114 by Rnf114 siRNA #1 or siRNA #2 or overexpression of Tab1 by Tab1 mRNA injection (shown in D. Scale bar = 25um.), the percentages of two-cell stage embryos with p65 nuclear translocation (shown in E.) were significantly decreased after Rnf114 knockdown or Tab1 overexpression (chi-square test was performed for statistical analysis).</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_5-F</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) Western blot analysis at 2-cell stage showed the levels of p-I&#954;B&#945; were downregulated in the Rnf114 siRNA #1, siRNA #2 injected groups.</text>
    </passage>
  </document>
  <document>
    <id>5286393 Figure_5-G</id>
    <infon key="sourcedata_document">2601</infon>
    <infon key="doi">10.15252/embr.201642573</infon>
    <infon key="pmc_id">5286393</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Western blot analysis at 2-cell stage showed the levels of p-I&#954;B&#945; were downregulated in the exogenous Tab1 mRNA injected groups, ddH2O was injected as control. Dotted line indicates a cropped lane.</text>
    </passage>
  </document>
</collection>
